Evaluation of the Efficacy of Cryotherapy Combined With Intralesional Hepatitis B Virus Vaccine Versus Either Therapy in the Treatment of Multiple Cutaneous Warts :a Comparative Study

NCT05902624 · Status: NOT_YET_RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-07-31

No results posted yet for this study

Summary

1. investigate the efficacy and safety of combined cryotherapy with intralesional HBV vaccine injection in the treatment of multiple common warts.
2. compare the efficacy and safety of the combined treatment versus either therapy in the treatment of multiple cutaneous warts.

Conditions

  • Cutaneous Warts

Interventions

DRUG

Hepatitis B Virus Vaccine(HBV)

Hepatitis B Virus Vaccine(HBV)

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Maria Awny, Master · Assiut University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2025-05-20
Completion
2025-08-20

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05902624 on ClinicalTrials.gov